A 22-year-old with cannabinoid hyperemesis syndrome died from a cardiac arrhythmia triggered by vomiting

A young woman with a 3.5-year history of cyclic vomiting and cannabis use died after developing torsades de pointes cardiac arrhythmia, linked to vomiting-induced hypokalemia and QT-prolonging medications.

von Both, Ingo et al.·Forensic science·2021·Preliminary EvidenceCase Report
RTHC-03598Case ReportPreliminary Evidence2021RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Case Report
Evidence
Preliminary Evidence
Sample
Not reported

What This Study Found

Death was attributed to fatal cardiac arrhythmia (torsades de pointes) complicating vomiting-induced hypokalemia in the context of cannabinoid hyperemesis syndrome, with contributing factors including QT-prolonging medications (haloperidol, ondansetron) and cardiac genetic mutations (MYBPC3 and RYR2).

Key Numbers

Patient age: 22. Cannabis use since age 14. Cyclic vomiting history: 3.5 years. Time to brain death: 4 days post-cardiac arrest. Genetic mutations identified: MYBPC3 and RYR2.

How They Did This

Case report with complete postmortem examination including histopathology, toxicology, and genetic testing. Clinical course documented from emergency department admission through brain death declaration 4 days later.

Why This Research Matters

This case demonstrates that cannabinoid hyperemesis syndrome can be fatal, not from the vomiting itself but from the downstream electrolyte disturbances and drug interactions that vomiting creates.

The Bigger Picture

CHS is often considered a nuisance condition, but this case illustrates a potentially fatal cascade: severe vomiting causes electrolyte depletion, which combined with certain medications can trigger lethal heart rhythms.

What This Study Doesn't Tell Us

Single case with multiple contributing factors (electrolyte disturbance, QT-prolonging drugs, genetic mutations), making it difficult to isolate any single cause.

Questions This Raises

  • ?Should QT-prolonging anti-emetics be avoided in CHS patients?
  • ?How common are undiagnosed cardiac channelopathies among CHS patients?

Trust & Context

Key Stat:
Fatal cardiac arrhythmia from vomiting-induced electrolyte depletion in CHS
Evidence Grade:
Thorough case report with complete postmortem workup, but single case with multiple confounders.
Study Age:
Published in 2021.
Original Title:
Death of a young woman with cyclic vomiting: a case report.
Published In:
Forensic science, medicine, and pathology, 17(4), 715-722 (2021)
Database ID:
RTHC-03598

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / Observational
Case Report / Animal StudyOne case or non-human subjects
This study

Describes what happened to one person or a small group.

What do these levels mean? →

Frequently Asked Questions

Can cannabinoid hyperemesis syndrome be fatal?

While rare, this case shows CHS can lead to death when severe vomiting causes dangerous electrolyte imbalances, especially when combined with medications that affect heart rhythm.

What medications contributed to the fatal outcome?

Haloperidol and ondansetron, both commonly used to treat nausea, can prolong the QT interval and increase the risk of dangerous heart rhythms, especially when potassium is low from vomiting.

Read More on RethinkTHC

Cite This Study

RTHC-03598·https://rethinkthc.com/research/RTHC-03598

APA

von Both, Ingo; Santos, Brittini. (2021). Death of a young woman with cyclic vomiting: a case report.. Forensic science, medicine, and pathology, 17(4), 715-722. https://doi.org/10.1007/s12024-021-00410-z

MLA

von Both, Ingo, et al. "Death of a young woman with cyclic vomiting: a case report.." Forensic science, 2021. https://doi.org/10.1007/s12024-021-00410-z

RethinkTHC

RethinkTHC Research Database. "Death of a young woman with cyclic vomiting: a case report." RTHC-03598. Retrieved from https://rethinkthc.com/research/von-2021-death-of-a-young

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.